Axsome Therapeutics Inc. (AXSM) NASDAQ

$79.80 0.63 (0.80%)

Market Cap: $3.75B

As of 03/28/24 04:00 PM EDT. Market closed.

(AXSM)

Axsome Therapeutics Inc. (AXSM)
NASDAQ

$79.80
0.63 (0.80%)

Market Cap: $3.75B

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

axsome therapeutics is a biopharmaceutical company developing novel therapies for the treatment of cns disorders. axsome has a balanced portfolio of clinical development stage as well as research stage product candidates. the company is based in new york ... read more

axsome therapeutics is a biopharmaceutical company developing novel therapies for the treatment of cns disorders. axsome has a balanced portfolio of clinical development stage as well as research stage product candidates. the company is based in new york city. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Herriot Tabuteau
Full Time Employees
353
CEO Compensation (Base)
$435,000
CEO Compensation (Total)
$1.06M
URL
Address
22 Cortlandt Street, 16Th Floor, New York, New York, 10007.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Herriot Tabuteau
Full Time Employees
353
CEO Compensation (Base)
$435,000
CEO Compensation (Total)
$1.06M
Address
22 Cortlandt Street, 16Th Floor, New York, New York, 10007.
PRICE CHART FOR AXSOME THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$79.55
Previous Close
$79.17
Days Range
$74.65 - $79.25
52 week range
$55.02 - $98.40
Volume
487,701
Avg. Volume (30 days)
855,186
Market Cap
$3.75B
Dividend Yield
-
P/E
(15.68)
Shares Outstanding
47,374,375
Open
$79.55
Previous Close
$79.17
Days Range
$74.65 - $79.25
52 week range
$55.02 - $98.40
Volume
487,701
Avg. Volume (30 days)
855,186
Market Cap
$3.75B
Dividend Yield
-
P/E
(15.68)
Shares Outstanding
47,374,375
FINANCIAL STATEMENTS FOR AXSOME THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR AXSOME THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
JEFFS ROGERDirectorMar 14, 2024 Option Exercise$24.0129,976719,787137,732Mar 15, 2024, 08:05 PM
JEFFS ROGERDirectorMar 15, 2024 Option Exercise$29.912,34770,199123,103Mar 15, 2024, 08:05 PM
JEFFS ROGERDirectorMar 14, 2024 Sale$69.7029,9762,089,387120,756Mar 15, 2024, 08:05 PM
JEFFS ROGERDirectorMar 15, 2024 Sale$71.612,347168,062120,756Mar 15, 2024, 08:05 PM
Coleman MarkDirectorSep 15, 2023 Option Exercise$3.6711,01640,42936,113Sep 15, 2023, 06:30 PM
Coleman MarkDirectorSep 15, 2023 Sale$75.1818,5721,396,189403,856Sep 15, 2023, 06:30 PM
Coleman MarkDirectorSep 15, 2023 Sale$75.1911,016828,24125,097Sep 15, 2023, 06:30 PM
Coleman MarkDirectorJan 03, 2023 Option Exercise$1.3017,50122,75125,097Jan 04, 2023, 04:11 PM
Coleman MarkDirectorMar 15, 2022 Option Exercise$1.303,4964,5457,596Mar 17, 2022, 07:05 AM
JEFFS ROGERDirectorNov 19, 2021 Buy$37.303,950147,350120,756Nov 23, 2021, 07:30 AM
Pizzie NickCHIEF FINANCIAL OFFICERNov 18, 2021 Buy$34.9742814,968201Nov 22, 2021, 07:31 AM
Pizzie NickCHIEF FINANCIAL OFFICERNov 18, 2021 Buy$35.5052718,70941,789Nov 22, 2021, 07:31 AM
Coleman MarkDirectorNov 18, 2021 Buy$35.091,43050,181422,428Nov 22, 2021, 07:30 AM
Saad Mark EDirectorNov 17, 2021 Buy$34.4230010,325100Nov 19, 2021, 07:30 AM
Saad Mark EDirectorNov 17, 2021 Buy$34.533,000103,59710,002Nov 19, 2021, 07:30 AM
Coleman MarkDirectorMay 12, 2021 Buy$58.1550029,075420,998May 13, 2021, 07:05 AM
Coleman MarkDirectorJun 29, 2020 Buy$78.5065051,025403,698Jun 30, 2020, 08:20 AM
Pizzie NickChief Financial OfficerJun 29, 2020 Buy$76.6477759,54941,217Jun 30, 2020, 08:19 AM
JEFFS ROGERDirectorJan 10, 2020 Option Exercise$10.4660,186629,756116,806Jan 14, 2020, 04:08 PM
Pizzie NickChief Financial OfficerSep 26, 2019 Buy$24.802,18054,06440,440Sep 30, 2019, 07:16 AM
JEFFS ROGERDirectorJul 03, 2019 Option Exercise$3.0456,620172,17856,620Jul 05, 2019, 07:00 AM
Coleman MarkDirectorJun 26, 2019 Buy$23.1015,800364,980668,848Jun 27, 2019, 07:18 AM
Coleman MarkDirectorJun 25, 2019 Buy$23.254009,300653,048Jun 27, 2019, 07:18 AM
Pizzie NickChief Financial OfficerJun 11, 2019 Buy$20.801,92039,9361,920Jun 12, 2019, 07:00 AM
Saad Mark EDirectorMay 23, 2019 Buy$22.333,50078,1557,002May 24, 2019, 07:19 AM
Coleman MarkDirectorMay 13, 2019 Buy$21.444,65099,696652,648May 15, 2019, 07:21 AM
Pizzie NickChief Financial OfficerMar 19, 2019 Buy$12.585,34067,17736,340Mar 21, 2019, 07:05 AM
Pizzie NickChief Financial OfficerMar 19, 2019 Buy$12.696076160Mar 21, 2019, 07:05 AM
Coleman MarkDirectorMar 19, 2019 Buy$12.185,10062,1185,100Mar 21, 2019, 07:05 AM
Pizzie NickChief Financial OfficerJun 19, 2018 Buy$3.1031,00096,08031,000Jun 20, 2018, 05:00 PM
JEFFS ROGERDirectorMar 29, 2017 Option Exercise$4.7342,538201,16346,912Mar 30, 2017, 04:31 PM
Kaye RandallChief Medical OfficerDec 23, 2015 Buy$9.031,0009,0266,022Dec 24, 2015, 01:02 PM
Ames ConstanceVice President, FinanceNov 24, 2015 Option Exercise$5.944,35825,8874,358Nov 24, 2015, 04:26 PM
Kaye RandallChief Medical OfficerNov 24, 2015 Option Exercise$5.405,02227,1195,022Nov 24, 2015, 04:26 PM
Coleman MarkDirectorNov 24, 2015 Option Exercise$5.71564,9483,224,166647,998Nov 24, 2015, 04:25 PM
JEFFS ROGERDirectorNov 24, 2015 Option Exercise$5.944,37425,9824,374Nov 24, 2015, 04:25 PM
Saad Mark EDirectorNov 24, 2015 Option Exercise$5.943,50220,8023,502Nov 24, 2015, 04:24 PM
TABUTEAU HERRIOTChief Executive OfficerNov 24, 2015 Option Exercise$5.947,22942,9407,229Nov 24, 2015, 04:24 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
JEFFS ROGERDirector03/14/2024719,787
JEFFS ROGERDirector03/15/202470,199
JEFFS ROGERDirector03/14/20242,089,387
JEFFS ROGERDirector03/15/2024168,062
Coleman MarkDirector09/15/202340,429
Coleman MarkDirector09/15/20231,396,189
Coleman MarkDirector09/15/2023828,241
Coleman MarkDirector01/03/202322,751
Coleman MarkDirector03/15/20224,545
JEFFS ROGERDirector11/19/2021147,350
Pizzie NickCHIEF FINANCIAL OFFICER11/18/202114,968
Pizzie NickCHIEF FINANCIAL OFFICER11/18/202118,709
Coleman MarkDirector11/18/202150,181
Saad Mark EDirector11/17/202110,325
Saad Mark EDirector11/17/2021103,597
Coleman MarkDirector05/12/202129,075
Coleman MarkDirector06/29/202051,025
Pizzie NickChief Financial Officer06/29/202059,549
JEFFS ROGERDirector01/10/2020629,756
Pizzie NickChief Financial Officer09/26/201954,064
JEFFS ROGERDirector07/03/2019172,178
Coleman MarkDirector06/26/2019364,980
Coleman MarkDirector06/25/20199,300
Pizzie NickChief Financial Officer06/11/201939,936
Saad Mark EDirector05/23/201978,155
Coleman MarkDirector05/13/201999,696
Pizzie NickChief Financial Officer03/19/201967,177
Pizzie NickChief Financial Officer03/19/2019761
Coleman MarkDirector03/19/201962,118
Pizzie NickChief Financial Officer06/19/201896,080
JEFFS ROGERDirector03/29/2017201,163
Kaye RandallChief Medical Officer12/23/20159,026
Ames ConstanceVice President, Finance11/24/201525,887
Kaye RandallChief Medical Officer11/24/201527,119
Coleman MarkDirector11/24/20153,224,166
JEFFS ROGERDirector11/24/201525,982
Saad Mark EDirector11/24/201520,802
TABUTEAU HERRIOTChief Executive Officer11/24/201542,940
Load More Insider Transactions
FUNDS WITH A POSITION IN AXSOME THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.3,239,7460.00657%10.4%Other
RA CAPITAL MANAGEMENT, L.P.1,000,0001.24%No changeOther
GEODE CAPITAL MANAGEMENT, LLC822,3040.00685%5.63%Other
ADAGE CAPITAL PARTNERS GP, L.L.C.365,0000.06%12.31%Other
DRIEHAUS CAPITAL MANAGEMENT LLC265,8420.25%6.81%Growth
FARALLON CAPITAL MANAGEMENT LLC4,0000.00158%-96.82%Event Driven, Value
WCM INVESTMENT MANAGEMENT, LLC104,8080.02%9.22%Growth At A Reasonable Price
HHLR ADVISORS, LTD.100,0000.16%ExitedOther
CANDRIAM S.C.A.85,0840.05%69.88%Other
ALPS ADVISORS INC32,4820.02%-6.74%Other
D. E. SHAW & CO., INC.34,600 (Call)0.00241%No changeOther
UBS OCONNOR LLC11,9220.07%-53.67%Value
AQR CAPITAL MANAGEMENT LLC8,3300.00125%-14.66%Other
D. E. SHAW & CO., INC.9,1840.00064%NewOther
CHANGE IN SHARES OUTSTANDING FOR AXSOME THERAPEUTICS INC
STOCK BUYBACKS FOR AXSOME THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.50%
1Q
12/31/2023
06/30/2023
8.43%
2Q
12/31/2023
03/31/2023
8.79%
3Q
12/31/2023
12/31/2022
8.91%
4Q
12/31/2023
09/30/2022
13.54%
5Q
12/31/2023
06/30/2022
21.16%
6Q
12/31/2023
03/31/2022
23.56%
7Q
12/31/2023
12/31/2021
25.38%
8Q
12/31/2023
09/30/2021
25.66%
9Q
12/31/2023
06/30/2021
25.95%
10Q
12/31/2023
03/31/2021
26.51%
11Q
12/31/2023
12/31/2020
26.77%
12Q
12/31/2023
09/30/2020
26.91%
13Q
12/31/2023
06/30/2020
27.63%
14Q
12/31/2023
03/31/2020
27.76%
15Q
12/31/2023
12/31/2019
36.20%
16Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.50%
1Q
06/30/2023
8.43%
2Q
03/31/2023
8.79%
3Q
12/31/2022
8.91%
4Q
09/30/2022
13.54%
5Q
06/30/2022
21.16%
6Q
03/31/2022
23.56%
7Q
12/31/2021
25.38%
8Q
09/30/2021
25.66%
9Q
06/30/2021
25.95%
10Q
03/31/2021
26.51%
11Q
12/31/2020
26.77%
12Q
09/30/2020
26.91%
13Q
06/30/2020
27.63%
14Q
03/31/2020
27.76%
15Q
12/31/2019
36.20%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR AXSOME THERAPEUTICS INC
LOADING...